Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) in FY2024

ELC (CFDA 93.323) crossed with FY2024

CFDA 93.323 and FY2024 are the two keys. $11,579,333,702.47 is their yearlyTrend obligation sum. CFDA 93.323 is Epidemiology and Laboratory Capacity for Infectious Diseases (ELC). FY2024 holds nearly the entire published 93.323 book; that still does not name laboratories. It is not every assistance dollar tagged to FY2024, not Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) restated without a year filter, and not an outlay. CFDA 93.323 (/programs/93.323/) holds the program rollup. FY2024 federal spending (/fiscal-years/2024/) holds the year rollup. Neither parent is this intersection.

Do not treat FEC receipts as the source of this CFDA-year cell. Donations and federal awards are different datasets even when geography overlaps. A chart that mixes CDC 93.283, immunization CFDAs, or NIH research lines with CFDA 93.323 in FY2024 has left this join. This page names no award recipients. The packet does not publish a test-kit inventory.

ELC as a CFDA label, not CDC 93.283

Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) is the CFDA title USAspending attaches to 93.323. Packet facts stop at that title, the year 2024, $11,579,333,702.47, 131 year-slice awards, $11,582,553,898.47 program-wide, and 133 parent awards. Place-of-performance, NAICS, and awarding-agency splits are omitted. Inventing 131 state public-health laboratories from the award-record count would over-read the field.

100.0% is $11,579,333,702.47 divided by $11,582,553,898.47. Equality or near-equality still does not name recipients. When the year slice is a minority of the book, other years on the same CFDA carry the rest. When the year slice is most of the book, other years still exist as separate ties if the parent counts differ. All programs (/programs/) and All spending ties (/ties/) stay available as indexes, not as addends.

FY2024 is almost the entire ELC book

FY2024 on CFDA 93.323 is not every ELC cooperative agreement closed in calendar 2024. Fiscal-year tagging can precede or follow performance. Current-year cells can move. Cite the snapshot as given: $11,579,333,702.47 in ELC infectious-disease capacity obligations in FY2024. Other yearlyTrend rows for the same CFDA are not this page. The year hub at /fiscal-years/2024/ does not require CFDA 93.323.

131 awards are not 131 laboratories

131 is the year-slice award-record count. It is not 131 state public-health laboratories. About $88,391,860.32 is $11,579,333,702.47 divided by 131, a packet quotient, not a median award. The parent lists 133 awards. Do not divide the FY2024 dollars by the parent count. Modifications can add lines without adding vendors. Unique recipients are unpublished.

ELC obligations are not tests already run

Obligations of $11,579,333,702.47 are commitments recorded on USAspending.gov. Outlays are unpublished on this packet, so none are invented. Keep Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) and FY2024 together. Open /programs/93.323/, /fiscal-years/2024/, /programs/, and /ties/ for the four parent or index views. None of them convert this cell into CDC 93.283, immunization CFDAs, or NIH research lines or into a contractor list. Keep Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) and FY2024 together when citing $11,579,333,702.47. CFDA 93.323 and fiscal year 2024 are the join keys. Obligations of $11,579,333,702.47 are not outlays. Original filings remain on USAspending.gov for this pair. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this program-year join. The All programs index and All spending ties index are larger than this cell. A later USAspending ingest can restate $11,579,333,702.47 without changing the join keys. 131 is the FY2024 award-record count, not 131 state public-health laboratories. About 100.0% locates FY2024 inside the $11,582,553,898.47 program book.

Questions

How much ELC infectious-disease capacity spending is in FY2024?

USAspending.gov records $11,579,333,702.47 in Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) obligations for fiscal year 2024 (CFDA 93.323). That is a program × year join, not an outlay and not all of FY2024 federal spending. The slice is about 100.0% of the program’s $11,582,553,898.47 extract total. Original filings remain on USAspending.gov.

Does CFDA 93.323 in FY2024 include CDC 93.283, immunization CFDAs, or NIH research lines?

No. This join is Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) (CFDA 93.323) × FY2024 only. CDC 93.283, immunization CFDAs, or NIH research lines would be other tables. $11,579,333,702.47 does not absorb those lines. Keep the CFDA number in the citation. Original filings remain on USAspending.gov.

Do 131 awards mean 131 state public-health laboratories?

No. 131 is the FY2024 award-record count on CFDA 93.323, not 131 state public-health laboratories. Unique recipients are unpublished. The implied mean is about $88,391,860.32, a quotient, not a typical award. Original filings remain on USAspending.gov.

Which pages parent ELC infectious-disease capacity in FY2024?

CFDA 93.323 at /programs/93.323/ is the program parent. FY2024 federal spending at /fiscal-years/2024/ is the year parent. All programs at /programs/ lists CFDA hubs. All spending ties at /ties/ lists other pairs. Prefer those tables after later ingests; this page quotes Epidemiology And Laboratory Capacity For Infectious Diseases (Elc) × FY2024 at $11,579,333,702.47.